DCF Advisers LLC Has $962,000 Stock Holdings in Teladoc Health, Inc. $TDOC

DCF Advisers LLC grew its stake in Teladoc Health, Inc. (NYSE:TDOC) by 292.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 137,500 shares of the health services provider’s stock after purchasing an additional 102,500 shares during the period. DCF Advisers LLC owned about 0.08% of Teladoc Health worth $962,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of TDOC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Teladoc Health by 2.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider’s stock worth $1,542,000 after purchasing an additional 5,235 shares during the last quarter. NewEdge Advisors LLC grew its position in Teladoc Health by 1,278.7% in the 1st quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider’s stock worth $90,000 after purchasing an additional 10,485 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Teladoc Health by 5.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider’s stock worth $3,566,000 after purchasing an additional 24,124 shares during the last quarter. Acadian Asset Management LLC acquired a new stake in Teladoc Health in the 1st quarter worth $615,000. Finally, Envestnet Asset Management Inc. acquired a new stake in Teladoc Health in the 2nd quarter worth $89,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Stock Up 2.4%

NYSE TDOC opened at $7.10 on Thursday. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. The stock’s 50 day moving average is $6.30 and its two-hundred day moving average is $6.22. The company has a market capitalization of $1.28 billion, a price-to-earnings ratio of -7.32 and a beta of 2.14. Teladoc Health, Inc. has a 1-year low of $4.40 and a 1-year high of $9.77.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The company had revenue of $613.85 million for the quarter, compared to analyst estimates of $611.04 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Equities analysts forecast that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Analysts Set New Price Targets

TDOC has been the topic of several research analyst reports. BMO Capital Markets decreased their price target on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating on the stock in a research report on Thursday, February 26th. Wells Fargo & Company cut their target price on Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating for the company in a research note on Thursday, February 26th. Barclays cut their target price on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Stifel Nicolaus cut their target price on Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research note on Thursday, February 26th. Finally, Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd. Five equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $7.43.

Insider Activity

In related news, insider Carlos Nueno sold 6,196 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $47,275.48. Following the completion of the sale, the insider owned 57,671 shares in the company, valued at $440,029.73. This trade represents a 9.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Fernando M. Rodrigues sold 5,677 shares of the stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $43,315.51. Following the sale, the insider owned 9,572 shares of the company’s stock, valued at $73,034.36. This trade represents a 37.23% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 39,870 shares of company stock worth $302,507. Company insiders own 0.70% of the company’s stock.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.